http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022103364-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c2901970e30a382f0ce84f21b4346fb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01B32-15
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B32-15
filingDate 2021-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87b4a2af3e59e86ae64dc7a466e928f1
publicationDate 2022-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022103364-A1
titleOfInvention Carbon nanoparticle synthesis method and use thereof for huvec cancer treatment
abstract The present invention relates to synthesis method of carbon nanoparticle solutions which can be produced in large quantities, used as carrier for drugs that are used in treatment process for cancer cells such as breast cancer (MCF-7) and human osteosarcoma (Saos-2) and which are also used for cancer treatment due to their ability to show cytotoxic effects against cancer cells in cell lines of human umbilical vein endothelial cells (HUVEC).
priorityDate 2020-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201534321-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020096318-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID493570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405563
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724

Total number of triples: 25.